pravastatin   Click here for help

GtoPdb Ligand ID: 2953

Synonyms: Lipostat® | Pravachol® | pravastatin sodium
Approved drug
pravastatin is an approved drug (FDA (1991))
Compound class: Synthetic organic
Comment: Pravastatin is a statin anti-dyslipidemia drug. Chemically the compound is a derivative of mevastatin (compactin), which was originally isolated from Penicillium citrinum.
Click here for help
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: pravastatin

2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 4
Rotatable bonds 11
Topological polar surface area 124.29
Molecular weight 424.25
XLogP 2.27
No. Lipinski's rules broken 1
Click here for help
Isomeric SMILES CC[C@@H](C(=O)O[C@H]1C[C@H](O)C=C2[C@H]1[C@@H](CC[C@H](C[C@H](CC(=O)O)O)O)[C@H](C=C2)C)C
InChI InChI=1S/C23H36O7/c1-4-13(2)23(29)30-20-11-17(25)9-15-6-5-14(3)19(22(15)20)8-7-16(24)10-18(26)12-21(27)28/h5-6,9,13-14,16-20,22,24-26H,4,7-8,10-12H2,1-3H3,(H,27,28)/t13-,14-,16+,17+,18+,19-,20-,22-/m0/s1
No information available.
Summary of Clinical Use Click here for help
Used in the treatment of hypercholesterolemia and to reduce the risk of cardiovascular disease. The EMA approved a fixed-mixture drug (Pravafenix®) in 2011 which contains pravastatin and fenofibrate.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Competitive inhibitor of HMG-CoA reductase, the enzyme catalysing the rate-limiting step of cholesterol synthesis. Acting primarily in the liver, pravastatin decreases hepatic cholesterol concentrations. The DrugBank record for this compound (accessed via the cross-link on the Summary tab) provides a comprehensive description of its molecular mechanism of action.
External links Click here for help